Peptonic signs license agreement with Prima Lab regarding self-test for urinary tract infections
PEPTONIC Medical AB announces that the company has signed a license agreement with Swiss medical technology company Prima Lab SA regarding self-tests for urinary tract infections for sale in Sweden.The agreement means that Peptonic gets the right to sell Prima Lab's self-test for urinary tract infections under its own brand VagiVital[®] in Sweden, with a planned launch at the end of 2023. "Urinary tract infections affect 40% of all women of all ages at some point in their lives, with many experiencing recurrent infections. Adding another high-quality self-test to the reference market